Tak Yun

3.1k total citations · 1 hit paper
81 papers, 2.3k citations indexed

About

Tak Yun is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Tak Yun has authored 81 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Oncology, 39 papers in Pulmonary and Respiratory Medicine and 19 papers in Surgery. Recurrent topics in Tak Yun's work include Lung Cancer Treatments and Mutations (28 papers), Lung Cancer Research Studies (15 papers) and Head and Neck Cancer Studies (11 papers). Tak Yun is often cited by papers focused on Lung Cancer Treatments and Mutations (28 papers), Lung Cancer Research Studies (15 papers) and Head and Neck Cancer Studies (11 papers). Tak Yun collaborates with scholars based in South Korea, United States and Ethiopia. Tak Yun's co-authors include Heung Tae Kim, Ji‐Youn Han, Jin Soo Lee, Hyae Young Kim, Myung‐Ju Ahn, Jong Hee Han, Sung Jin Yoon, Keunchil Park, Cheolwon Suh and Dae Ho Lee and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Tak Yun

77 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

First-SIGNAL: First-Line Single-Agent Iressa Versus Gemcitabine and Cisplatin Trial in Never-Smokers With Adenocarcinoma of the Lung

2012 611 citations Ji‐Youn Han, Hyae Young Kim et al. profile →

Peers

Tak Yun

ONCOL

PRM

SURGE

V.A. Miller United States

Joo Hang Kim South Korea

Hideki Kimura Japan

Shunzo Hatooka Japan

Veronica Lonati Italy

Daisuke Takahari Japan

Guillermo López-Vivanco Spain

Thomas Brodowicz Austria

Takehito Shukuya Japan

Mitsuhiro Takenoyama Japan

V.A. Miller United States

Tak Yun

2.1k ×1.5

ONCOL

1.6k ×1.3

PRM

924 ×1.5

508 ×1.1

323 ×0.8

SURGE

Citations per year, relative to Tak Yun Tak Yun (= 1×) peers V.A. Miller

Countries citing papers authored by Tak Yun

Since Specialization

Citations

This map shows the geographic impact of Tak Yun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tak Yun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tak Yun more than expected).

Fields of papers citing papers by Tak Yun

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tak Yun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tak Yun. The network helps show where Tak Yun may publish in the future.

Co-authorship network of co-authors of Tak Yun

This figure shows the co-authorship network connecting the top 25 collaborators of Tak Yun. A scholar is included among the top collaborators of Tak Yun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tak Yun. Tak Yun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kim, Min Kyoung, Keon Uk Park, Tak Yun, et al.. (2025). Differential Efficacy of Alpelisib by PIK3CA Mutation Site in Head and Neck Squamous Cell Carcinoma: An Analysis from the KCSG HN 15-16 TRIUMPH Trial. Cancer Research and Treatment. 57(4). 968–980. 1 indexed citations

Lim, Yoojoo, Chan‐Young Ock, Gahee Park, et al.. (2023). Artificial intelligence‐powered spatial analysis of tumor‐infiltrating lymphocytes as a predictive biomarker for axitinib in adenoid cystic carcinoma. Head & Neck. 45(12). 3086–3095. 5 indexed citations

Choi, Wonyoung, Youngjoo Lee, Beom K. Choi, et al.. (2023). Phase 1 trial of 4-1BB-based adoptive T-cell therapy targeting human telomerase reverse transcriptase in patients with advanced refractory solid tumors. Cytotherapy. 25(11). 1236–1241. 3 indexed citations

Jung, Hyun Ae, Keon Uk Park, Sang‐Hee Cho, et al.. (2022). A Phase II Study of Nivolumab plus Gemcitabine in Patients with Recurrent or Metastatic Nasopharyngeal Carcinoma (KCSG HN17–11). Clinical Cancer Research. 28(19). 4240–4247. 18 indexed citations

Kang, Eun Joo, Myung‐Ju Ahn, Chan-Young Ock, et al.. (2021). Randomized Phase II Study of Axitinib versus Observation in Patients with Recurred or Metastatic Adenoid Cystic Carcinoma. Clinical Cancer Research. 27(19). 5272–5279. 39 indexed citations

Lee, Sung Uk, Sung Ho Moon, Sung Weon Choi, et al.. (2020). Prognostic significance of smoking and alcohol history in young age oral cavity cancer. Oral Diseases. 26(7). 1440–1448. 13 indexed citations

Eom, Hyeon‐Seok, Beom K. Choi, Youngjoo Lee, et al.. (2016). Phase I Clinical Trial of 4-1BB-based Adoptive T-Cell Therapy for Epstein-Barr Virus (EBV)-positive Tumors. Journal of Immunotherapy. 39(3). 140–148. 17 indexed citations

Lee, Youngjoo, Geon Kook Lee, Byung‐Ho Nam, et al.. (2014). Clinical outcome according to the level of preexisting epidermal growth factor receptor T790M mutation in patients with lung cancer harboring sensitive epidermal growth factor receptor mutations. Cancer. 120(14). 2090–2098. 52 indexed citations

Han, Ji‐Youn, Soo Hyun Lee, Geon Kook Lee, et al.. (2014). Phase I/II study of gefitinib (Iressa®) and vorinostat (IVORI) in previously treated patients with advanced non-small cell lung cancer. Cancer Chemotherapy and Pharmacology. 75(3). 475–483. 48 indexed citations

10.

Lee, Young Joo, Kyong‐Ah Yoon, Ji‐Youn Han, et al.. (2011). Circulating Cell-Free DNA in Plasma of Never Smokers with Advanced Lung Adenocarcinoma Receiving Gefitinib or Standard Chemotherapy as First-Line Therapy. Clinical Cancer Research. 17(15). 5179–5187. 64 indexed citations

11.

Yun, Tak, Ji‐Youn Han, Jin Soo Lee, et al.. (2011). Phase II study of weekly paclitaxel and capecitabine in patients with metastatic or recurrent esophageal squamous cell carcinoma. BMC Cancer. 11(1). 385–385. 21 indexed citations

12.

Han, Ji‐Youn, Kun Young Lim, Sun Yu, et al.. (2010). A phase 2 study of irinotecan, cisplatin, and simvastatin for untreated extensive‐disease small cell lung cancer. Cancer. 117(10). 2178–2185. 40 indexed citations

13.

Yun, Tak. (2009). Targeted therapy and tailored chemotherapy for advanced non-small cell lung cancer. The Korean Journal of Internal Medicine. 77(1). 9–17. 1 indexed citations

14.

Han, Mi Hwa, Hyeon‐Seok Eom, Weon Seo Park, et al.. (2009). Detection of circulating lymphoma cells in patients with non-Hodgkin lymphoma using MAGE-A3 gene expression in peripheral blood. Leukemia Research. 34(9). 1127–1131. 6 indexed citations

15.

Song, Eun‐Kee, et al.. (2007). Efficacy of chemotherapy as a first-line treatment in ocular adnexal extranodal marginal zone B-cell lymphoma. Annals of Oncology. 19(2). 242–246. 46 indexed citations

16.

Na, Im Il, Tak Yun, Keun‐Wook Lee, et al.. (2006). Acute myelogenous Leukemia in the elderly ($\geq$60): retrospective study of 115 patients. The Korean Journal of Internal Medicine. 70(2). 196–206. 2 indexed citations

17.

Lee, Keun‐Wook, Tak Yun, Seock‐Ah Im, et al.. (2006). First-line ifosfamide, methotrexate, etoposide and prednisolone chemotherapy ± radiotherapy is active in stage I/II extranodal NK/T-cell lymphoma. Leukemia & lymphoma. 47(7). 1274–1282. 43 indexed citations

18.

Kim, Dae Yong, Kyung Hae Jung, Tae Hyun Kim, et al.. (2006). Comparison of 5-fluorouracil/leucovorin and capecitabine in preoperative chemoradiotherapy for locally advanced rectal cancer. International Journal of Radiation Oncology*Biology*Physics. 67(2). 378–384. 82 indexed citations

19.

Lee, Keun‐Wook, Tak Yun, Im Il Na, et al.. (2005). A Pilot Study of Bortezomib in Korean Patients with Relapsed or Refractory Myeloma. Journal of Korean Medical Science. 20(4). 598–598. 4 indexed citations

20.

Lee, Keun‐Wook, Jongyoun Yi, Tak Yun, et al.. (2004). Extramedullary Relapse Confirmed by Fluorescence In Situ Hybridization Study of an Ear Mass in Acute Promyelocytic Leukemia. International Journal of Hematology. 79(5). 462–464. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact